semaglutide
Experts Agree: 30% Faster Prescription Weight Loss
Experts Agree: 30% Faster Prescription Weight Loss In the latest tirzepatide trial, participants lost 30% more weight than those on placebo, suggesting a faster path to clinically meaningful loss. The data also show comparable safety to earlier GLP-1 agents, positioning tirzepatide as a strong option for obesity management. Medical Disclaimer: